Effect of sulforaphane on cell growth, G0/G1 phase cell progression and apoptosis in human bladder cancer T24 cells

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 883-888

  Shan, Yujuan ^a,b   Sun, Changhao ^a   Zhao, Xiujuan ^a   Wu, Kun ^a   Cassidy, Aedin ^b   Bao, Yongping ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Apoptosis; Bladder; Cell cycle; Isothiocyanate; Sulforaphane

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLIN DEPENDENT KINASE INHIBITOR 1B; SULFORAFAN; THIOCYANIC ACID DERIVATIVE;

APOPTOSIS; ARTICLE; BLADDER TUMOR; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; DRUG EFFECT; HUMAN; IC 50; METABOLISM; UPREGULATION;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE; CELL NUCLEUS; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; INHIBITORY CONCENTRATION 50; THIOCYANATES; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 34247622975     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.883     Document Type: Article

References (39)

1. Larsson SC, Hakansson N, Naslund I, Bergkvist L and Wolk A: Fruit and vegetable consumption in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 15: 301-305, 2006. (Pubitemid 43342178)
2. Pan SY, Ugnat AM, Mao Y, Wen SW and Johnson KC: A case-control study of diet and the risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 13: 1521-1527, 2004. (Pubitemid 39202321)
3. Brennan P, Hsu CC, Moullan N, et al: Effect of cruciferous vegetables on lung cancer in patients stratified by genetic status: a mendelian randomisation approach. Lancet 366: 1558-1560, 2005.
4. Hara M, Hanaoka T, Kobayashi M, et al: Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer 46: 138-147, 2003.
5. Kellen E, Zeegers M, Paulussen A, van Dongen M and Buntinx F: Fruit consumption reduces the effect of smoking on bladder cancer risk. The Belgian case control study on bladder cancer. Int J Cancer 118: 2572-2578, 2006.
6. Holick CN, De Vivo I, Feskanich D, Giovannucci E, Stampfer M and Michaud DS: Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States). Cancer Causes Control 16: 1135-1145, 2005.
7. Michaud DS, Spiegelman D, Clinton SK, et al: Fluid intake and the risk of bladder cancer in men. N Engl J Med 340: 1390-1397, 1995. (Pubitemid 29205402)
8. Hirose M, Yamaguchi T, Kimoto N, Ogawa K, Futakuchi M, Sano M and Shirai T: Strong promoting activity of phenylethyl isothiocyanate and benzyl isothiocyanate on urinary bladder carcinogenesis in F344 male rats. Int J Cancer 77: 773-777, 1998. (Pubitemid 28341396)
9. Okazaki K, Yamagishi M, Son HY, et al: Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). Nutr Cancer 42: 211-216, 2002.
10. Langouet S, Furge LL, Kerriguy N, Nakamura K, Guillouzo A and Guengerich FP: Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Chem Res Toxicol 13: 245-252, 2000.
11. Basten GP, Bao Y and Williamson G: Sulforaphane and its glutathione conjugate but not sulforaphane nitrile induce UDP-glucuronosyl transferase (UGT1A1) and glutathione transferase (GSTA1) in cultured cells. Carcinogenesis 23: 1399-1404, 2002.
12. Bacon JR, Williamson G, Garner RC, Lappin G, Langouet S and Bao Y: Sulforaphane and quercetin modulate PhIP-DNA adduct formation in human HepG2 cells and hepatocytes. Carcinogenesis 24: 1903-1911, 2003.
13. Zhang Y, Tang L and Gonzalez V: Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol Cancer Ther 2: 1045-1052, 2003.
14. Gamet-Payrastre L, Li P, Lumeau S, et al: Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res 60: 1426-1433, 2000. (Pubitemid 30152017)
15. Myzak MC, Karplus PA, Chung FL and Dashwood RH: A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 64: 5767-5774, 2004.
16. Jackson SJ and Singletary KW: Sulforaphane inhibits human MCF-7 mammary cancer cell mitotic progression and tubulin polymerization. J Nutr 134: 2229-2236, 2004.
17. Tang L, Li G, Song L and Zhang Y: The principal urinary metabolites of dietary isothiocyanates, N-acetylcysteine conjugates, elicit the same anti-proliferative response as their parent compounds in human bladder cancer cells. Anticancer Drugs 17: 297-305, 2006.
18. Sanchini MA, Gunelli R, Nanni O, et al: Relevance of urine telomerase in the diagnosis of bladder cancer. JAMA 294: 2052-2056, 2005.
19. Gu J, Zhao H, Dinney CP, et al: Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res 11: 1408-1415, 2005. (Pubitemid 40315220)
20. Braakhuis BJ, Tabor MP, Kummer JA, Leemans CR and Brakenhoff RH: A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications. Cancer Res 63: 1727-1730, 2003.
21. Califano J, Leong PL, Koch WM, Eisenberger CF, Sidransky D and Westra WH: Second esophageal tumors in patients with head and neck squamous cell carcinoma: an assessment of clonal relationships. Clin Cancer Res 5: 1862-1867, 1999.
22. Potter JD: Colorectal cancer: molecules and populations. J Natl Cancer Inst 91: 916-932, 1999.
23. Tsao AS, Kim ES and Hong WK: Chemoprevention of cancer. CA Cancer J Clin 54: 150-180, 2004.
24. Greenwald P: Science, medicine, and the future: cancer chemoprevention. BMJ 324: 714-718, 2002.
25. Hursting SD, Slaga TJ, Fischer SM, Giovanni JD and Phang JM: Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J Natl Cancer Inst 91: 215-225, 1999.
26. Kelloff GJ, Crowell JA, Steele VE, et al: Progress in cancer chemoprevention: development of diet-derived chemopreventive agents. J Nutr 130: 467S-471S, 2000.
27. Zhang Y: Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res 555: 173-190, 2004.
28. Ogawa K, Hirose M, Sugiura S, Cui L, Imaida K, Ogiso T and Shirai T: Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis. Nutr Cancer 40: 134-139, 2001. (Pubitemid 34274919)
29. Sugiura S, Ogawa K, Hirose M, Takeshita F, Asamoto M and Shirai T: Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated with phenylethyl isothiocyanate. Carcinogenesis 24: 547-553, 2003. (Pubitemid 36432652)
30. Tang L and Zhang Y: Dietary isothiocyanates inhibit the growth of human bladder carcinoma cells. J Nutr 134: 2004-2010, 2004.
31. Tang L and Zhang Y: Isothiocyanates in the chemoprevention of bladder cancer. Curr Drug Metab 5: 193-201, 2004.
32. Jakubíková J, Bao YP and Sedlák J: Isothiocyanates induce cell cycle arrest, apoptosis and mitochondrial potential depolarization in HL-60 and multidrug-resistant cell lines. Anticancer Res 25: 3375-3386, 2005.
33. Zhang Y and Talalay P: Mechanisms of differential potencies of isothiocyanates as inducers of anticarcinogenic phase 2 enzymes. Cancer Res 58: 4632-4639, 1998.
34. Zhang Y: Role of glutathione in the accumulation of anticarcinogenic isothiocyanates and their glutathione conjugates by murine hepatoma cells. Carcinogenesis 21: 1175-1182, 2000.
35. Zhang Y: Molecular mechanism of rapid cellular accumulation of anticarcinogenic isothiocyanates. Carcinogenesis 22: 425-431, 2001.
36. Zhang Y and Callaway EC: High cellular accumulation of sulphoraphane, a dietary anticarcinogen, is followed by rapid transporter-mediated export as a glutathione conjugate. Biochem J 364: 301-307, 2002.
37. Massague J: G1 cell-cycle control and cancer. Nature 432: 298-306, 2004.
38. Murray AW: Recycling the cell cycle: cyclins revisited. Cell 116: 221-234, 2004.
39. Malumbres M, Sotillo R, Santamaria D, et al: Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6. Cell 118: 493-504, 2004. (Pubitemid 39485668)